Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8651303 | The American Journal of Cardiology | 2018 | 23 Pages |
Abstract
In patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI), lack of ST-segment resolution (STR) is associated with poor prognosis at short- and long-term follow-up. The aim of this study was to evaluate the role of STR on very long-term outcomes in patients with STEMI treated with pPCI included in the EXAMINATION (Evaluation of the Xience-V Stent in Acute Myocardial Infarction) trial. Patients were stratified according to the presence of STRâ<â50% and STRâ<â70% at the 30-minute post-pPCI electrocardiogram. Primary end point was the patient-oriented composite endpoint (POCE) of all-cause death, any myocardial infarction, or any revascularization at 5-year follow-up. Both baseline and post-PCI 30-minute electrocardiograms were available for STR assessment in 1,351 patients. Of these patients, 228 (16.9%) and 500 (37.0%) exhibited STRâ<â50% and STRâ<â70%, respectively. At 5-year follow-up, the POCE was observed more frequently in patients with STRâ<â50% (hazard ratio [HR] 1.556; 95% confidence interval [CI] 1.194 to 2.027; pâ<0.001) and in patients with STRâ<â70% (HR 1.460, 95% CI 1.169 to 1.824, pâ<0.001) compared with patients with STRâ>â50% and STRââ¥â70%, respectively. In both cases, this difference was mainly driven by a significant increase in the rate of all-cause death and any revascularization. After multivariable adjustment, STRâ<â70%, but not STRâ<â50%, resulted as a 5-year independent predictor of POCE (adjusted HR 1.338, 95% CI 1.008 to 1.778, pâ=â0.044). In conclusion, in patients with STEMI, the evaluation of 70% STR after pPCI provides independent prognostic information at 5-year follow-up and it can be used to identify patients at high risk of very long-term cardiovascular events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Giosafat MD, Salvatore MD, PhD, Giancarla MD, Elisabetta MD, Luis MD, Alberto MD, Josep MD, PhD, Angel MD, Andrés MD, Antonio MD, Pilar MD, Vicente MD, Gianluca MD, Maurizio MD, Peter MD, Armando MD, Nicolás MD, Marco MD, PhD, Manel MD, PhD,